Dermatology 2023 | International Conference on Dermatology and cosmetology

Study reports a significant increase in syphilis cases in India, highlighting the need for effective prevention and treatment despite the availability of effective therapies. source https://www.news-medical.net/news/20240131/Syphilis-A-silent-epidemic-reawakens.aspx

Researchers identified patient- and tumor-level melanoma features in black individuals. source https://www.news-medical.net/news/20240125/Study-addresses-knowledge-gap-of-clinical-features-and-outcomes-of-Black-patients-with-melanoma.aspx

A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. source https://www.news-medical.net/news/20240123/Scientists-identify-a-new-approach-to-treating-sarcoidosis.aspx

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer. source https://www.news-medical.net/news/20240119/Immune-checkpoint-inhibitor-target-found-to-promote-skin-cancer-growth.aspx

Children with the condition aplasia cutis congenita (ACC) are born with the absence of skin along the midline of the scalp. source https://www.news-medical.net/news/20240103/Missing-proteins-explain-century-old-mystery-of-scalp-skin-absence-in-children.aspx

Researchers at the Icahn School of Medicine at Mount Sinai have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues. source https://www.news-medical.net/news/20231221/Unraveling-nuanced-roles-of-JAK-inhibitors-in-inflammation.aspx

New research indicates that higher doses of topical corticosteroids, which are commonly used to treat inflammatory skin conditions, are linked with elevated risks of osteoporosis and bone fractures associated with osteoporosis. source https://www.news-medical.net/news/20231220/Higher-doses-of-topical-corticosteroids-linked-to-increased-risks-of-osteoporosis-and-bone-fractures.aspx

Study reveals racial disparities in Lyme disease diagnosis and treatment, with Black patients experiencing longer delays and higher risks of disseminated disease compared to White patients. source https://www.news-medical.net/news/20231214/Study-exposes-racial-disparities-in-Lyme-disease-diagnosis-and-treatment-times.aspx

SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study. source https://www.news-medical.net/news/20231212/SolasCure-demonstrates-proof-of-concept-in-Phase-lla-safety-trial-of-Aurase-Wound-Gel.aspx

Study explores optimizing large language models (LLMs) for differential diagnosis (DDx), demonstrating their potential in assisting clinicians with accurate disease diagnosis using real-world medical cases. source https://www.news-medical.net/news/20231207/Large-language-models-enhance-differential-diagnosis-paving-the-way-for-AI-assisted-medical-decision-making.aspx

Study reveals societal stigma and negative stereotypes associated with acne, highlighting the need for greater awareness and understanding of this skin condition. source https://www.news-medical.net/news/20231207/Study-exposes-societal-stigma-and-misconceptions-about-acne.aspx

A new study highlights how stigmatizing attitudes about individuals with acne may influence social and professional perceptions. source https://www.news-medical.net/news/20231206/Individuals-with-acne-face-stigmatizing-attitudes-from-the-general-public-study-finds.aspx

A recent Federal Trade Commission civil lawsuit accusing one of the nation's largest anesthesiology groups of monopolistic practices that sharply drove up prices is a warning to private equity investors that could temper their big push to snap up physician groups. source https://www.news-medical.net/news/20231130/FTC-chief-gears-up-for-a-showdown-with-private-equity.aspx

A heat shock protein protects the cells against protein clumping. It degrades, however, over longer treatment periods. source https://www.news-medical.net/news/20231124/Heat-shock-protein-protects-bacteria-from-plasma-treatment.aspx

As an extremely aggressive form of skin cancer, cutaneous melanoma is still associated with a high mortality rate. Enormous progress has recently been made in the fight against deadly metastasis, but existing therapeutic measures are still not effective in many cases. source https://www.news-medical.net/news/20231121/Researchers-discover-new-option-to-target-the-metastatic-capacity-of-melanoma-cells.aspx

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, and Absci Corporation, a generative AI drug creation company, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation. source https://www.news-medical.net/news/20231120/Almirall-and-Absci-partner-to-develop-AI-designed-therapeutics-for-dermatological-diseases.aspx

Money talks. The United States faces a serious shortage of primary care physicians for many reasons, but one, in particular, is inescapable: compensation. source https://www.news-medical.net/news/20231116/Compensation-is-key-to-fixing-primary-care-shortage.aspx

The Paul G. Allen Frontiers Group, a division of the Allen Institute, today announced the launch of the Allen Discovery Center (ADC) for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai. source https://www.news-medical.net/news/20231109/Allen-Discovery-Center-for-Neuroimmune-Interactions-launched-at-Mount-Sinai.aspx

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University. source https://www.news-medical.net/news/20231106/New-pathologic-scoring-system-could-help-predict-survival-in-lung-cancer-patients.aspx

A marijuana-like compound holds out promise as a new treatment for a severe autoimmune skin disease called skin lupus, according to a study published recently by a multicenter team including researchers at the George Washington University. source https://www.news-medical.net/news/20231102/Marijuana-like-compound-shows-promise-as-new-treatment-for-skin-lupus.aspx